Insulin Detemir Reduces Hypoglycemic Risk at Comparable HbAfc Values Compared to NPH Insulin in Patients with Type 1 Diabetes

被引：0

|

作者：

Hermansen, Kjeld

Heller, Simon

Andersen, Marc

Russell-Jones, David L.

机构：

来源：

DIABETES | 2009年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A529 / A530

页数：2

相关论文

共 50 条

[31] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes
Heise, T
Nosek, L
Draeger, E
Stender, A
Ronn, BB
Kapitza, C
Heinemann, L
DIABETES, 2003, 52 : A121 - A121
[32] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
Heise, T
Nosek, L
Ronn, BB
Endahl, L
Heinemann, L
Kapitza, C
Draeger, E
DIABETES, 2004, 53 (06) : 1614 - 1620
[33] Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes
Ma, Zhulin
Christiansen, Jens Sandahl
Laursen, Torben
Lauritzen, Torsten
Frystyk, Jan
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (04) : 471 - 479
[34] Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes
Pfutzner, A
Kustner, E
Forst, T
SchulzeSchleppinghoff, B
Trautmann, ME
Haslbeck, M
Schatz, H
Beyer, J
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 (01) : 25 - 30
[35] Cost-utility analysis of insulin glargine compared with NPH insulin in patients with type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
De Pablos, P
DIABETES, 2004, 53 : A291 - A292
[36] Short-term Effects of NPH Insulin, Insulin Detemir, and Insulin Glargine on the IGF-IGFBP-GH Axis in Patients with Type 1 Diabetes
Frystyk, Jan
Ma, Zhulin
Laursen, Torben
Lauritzen, Torsten
Christiansen, Jens S.
DIABETES, 2014, 63 : A489 - A490
[37] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
Morales, Cristobal
de Luis, Daniel
Ramirez de Arellano, Antonio
Giovanna Ferrario, Maria
Lizan, Luis
DIABETES THERAPY, 2015, 6 (04) : 593 - 610
[38] Cost-effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Portugal
Cardoso, Cristina
Ramirez de Arellano, Antonio
Prades, Miriam
Lizan, Luis
JOURNAL OF DIABETES & METABOLISM, 2016, 7 (03)
[39] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
Cristóbal Morales
Daniel de Luis
Antonio Ramírez de Arellano
Maria Giovanna Ferrario
Luis Lizán
Diabetes Therapy, 2015, 6 : 593 - 610
[40] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
Terres, CR
Rodríguez, J
Bolinder, B
De Pablos, P
DIABETES, 2004, 53 : A291 - A291

← 1 2 3 4 5 →